Impact of Signal Peptides on Furin-2A Mediated Monoclonal Antibody Secretion in CHO Cells

Biotechnol J. 2017 Sep;12(9). doi: 10.1002/biot.201700268. Epub 2017 Aug 14.

Abstract

Studies had shown the benefits of using furin-2A peptides for high monoclonal antibody (mAb) expression in mammalian cells. How signal peptides affect furin-2A mediated mAb secretion has yet to be investigated. The impact of signal peptides on mAb secretion in furin-2A based tricistronic vectors in CHO cells is evaluated. In each tricistronic vector, heavy chain (HC) is arranged as the first cistron and followed by a furin recognition sequence, a 2A peptide, light chain (LC), an internal ribosome entry site (IRES), and dihydrofolate reductase (DHFR). Signal peptides for HC and LC are either removed or changed in different vectors. The vectors with signal peptides on both HC and LC genes gIve the highest mAb secretion levels. Changing to signal peptides with different strengths on either HC or LC do not change the mAb secretion level. IgG is still secreted when the signal peptide on the LC gene is removed but at a lower level compared to the vectors containing signal peptides on both HC and LC genes. Removing the HC signal peptide results in almost no IgG secretion regardless of whether the downstream LC carries any signal peptide. Removing the furin cleavage site does not affect mAb secretion levels while removing the 2A sequence results in low mAb secretion. The results present here will be beneficial for designing furin-2A based vectors for expressing mAb in mammalian cells.

Keywords: 2A peptide; CHO; furin; monoclonal antibody; signal peptide.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / chemistry
  • Antibodies, Monoclonal / genetics
  • Antibodies, Monoclonal / metabolism*
  • Bevacizumab
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Furin / chemistry
  • Furin / genetics
  • Furin / metabolism*
  • Protein Sorting Signals / genetics*
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism*
  • Transfection
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Protein Sorting Signals
  • Recombinant Fusion Proteins
  • Bevacizumab
  • Furin
  • Trastuzumab